Related Experiment Video
Updated: Feb 5, 2026
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Dental Implant Therapy on a Patient With von Willebrand Disease: A Case Study
1Private Practice, Fairfield County, Connecticut.
Background:
Von Willebrand disease (vWD) is the most common hereditary disorder affecting coagulation. Patients with this disorder are at a higher risk of postoperative complications after dental surgery. This article discusses the successful treatment for a patient with vWD undergoing implant therapy.
Case Description:
A young 21-year-old patient with vWD lost tooth #30 because of caries and required implant therapy. Through collaboration with a hematologist administering prophylactic desmopressin (DDAVP), the implant surgery was performed without any postoperative complications. The implant successfully integrated and was restored into function. The successful outcome met expectations after careful planning and execution.
Practical Implications:
Collaboration with the appropriate medical providers, as well as treatment modifications for surgical procedures during implant therapy, is necessary for successful treatment of a patient with von Willebrand disorder.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
00:59Gene Therapy
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:26Group Therapy
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...